- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05916027
Identification and Treatment of Alcohol Problems in Primary Care (iTAPP)
iTAPP Study - Identification and Treatment of Alcohol Problems in Primary Care
The Identification and Treatment of Alcohol Problems in Primary Care (iTAPP) Study is a pragmatic cluster randomized controlled intervention trial evaluating the effectiveness of the 15-Method as an identification and treatment tool for alcohol-related problems in Danish general practice. The 15-Method combines evidence-based approaches from specialized addiction treatment with screening and readily available treatment options in general practice to help identify and treat alcohol problems in a primary care setting. The method has shown promising results as a treatment tool in Sweden. A feasibility study of the 15-Method in Denmark suggested that the method can be implemented in Danish general practice.
The trial is led by the Unit for Clinical Alcohol Research at The University of Southern Denmark in collaboration with The Research Unit of General Practice Odense at The University of Southern Denmark.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Fynen
-
Odense C, Fynen, Denmark, 5000
- Unit for Clinical Alcohol Research, Clinical Institute, University of Southern Denmark
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years or older
- Affiliated with the participating general practices
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Each participating clinic serves as its own control and as control for active clinics, in the stepped-wedge design.
All clinics are inactive (no intervention) during the baseline period of three months.
|
|
Active Comparator: Active
Active clinics are trained in the intervention object (the 15-method) prior to switching to the active group.
Clinics are enrolled as active clinics (intervention) in four steps (4-5 clinics in each step).
The intervention is implemented into the clinic, and the staff are free to use the intervention in everyday work.
|
The 15-Method is a Screening and Brief Intervention method for identifying and treating alcohol problems in primary care.
The method combines evidence-based approaches from specialized addiction treatment with screening and readily available treatment options in general practice to help identify and treat alcohol problems.
The 15-method is based on Motivational Interviewing, Cognitive Behavioral Therapy and utilizes the Alcohol Use Disorder Identification Test (AUDIT) as a screening tool.
The 15-Method contains three flexible steps: Identification of clinical problem related to alcohol; feedback and clinical work-up as needed; treatment.
Treatment includes structured consultations (maximum of four) with patient home-work assignments, and can be combined with pharmacological treatment for alcohol problems.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of alcohol related conversations in the clinics
Time Frame: Up to 19 months
|
The total number of consultations in which the topic of alcohol has been addressed. Outcome measure on the level of the practices (i.e. not patients). Alcohol related conversations are continuously registered in the patient filing system throughout the study period. Comparison of baseline frequency (pre-implementation) to post-implementation frequencies |
Up to 19 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of patients who exceed the Danish national recommendations of alcohol consumption
Time Frame: 4 times of 10 minutes
|
Data type: survey Level: population Variables: The Alcohol Use Disorder Identification Test Scores (0-40 points) and the Timeline Follow Back one-week version (number of standard drinks, 12g of ethanol, per week) Comparison of baseline (pre-implementation) and post-implementation levels
|
4 times of 10 minutes
|
Quality of Life 5D-5L scores
Time Frame: 4 times of 10 minutes
|
Data: Survey Level: population Variable: Quality of life score by The World Health Organization 5D-5L questionnaire.
|
4 times of 10 minutes
|
Pharmacological Treatment
Time Frame: 0-4 sessions of 15 minutes
|
The use of pharmacological treatment for alcohol problems in the clinics will be analyzed, comparing baseline levels to active (post-implementation) levels. Data: register based Level: practices Variables: prescription rates of Disulfiram, Naltrexone, Acamprosate, and Nalmefene |
0-4 sessions of 15 minutes
|
Use of blood sampling
Time Frame: 0-4 sessions of 15 minutes
|
The use of blood sampling as screening/monitoring for potential alcohol problems in the clinics will be analyzed, comparing baseline levels to active (post-implementation) levels. Data: register based Level: practices Blood variables: Gamma-Glutamyltransferase (GGT) and Alanine-Aminotransferase (ALAT). |
0-4 sessions of 15 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Anette S Nielsen, Professor, Unit of Clinical Alcohol Research, University of Southern Denmark
- Principal Investigator: Jens Søgaard, Professor, Research Unit of General Practice Odense, University of Southern Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- iTAPP project
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on General Practice
-
Université de Reims Champagne-ArdenneNot yet recruitingGeneral PracticeFrance
-
Aalborg UniversityCompletedUltrasound | General PracticeDenmark
-
University Hospital, CaenCompletedUltrasonography | Education | General PracticeFrance
-
Aalborg UniversityCompletedUltrasound | General Practice | DiagnosticsDenmark
-
Charles University, Czech RepublicCompletedPhysical Activity | General Practice | Primary Care
-
Brno University HospitalKrajská zdravotní a.s. University Hospital Ústí nad LabemUnknown
-
University of ExeterUniversity of Leeds; National Institute for Health Research, United KingdomUnknownAged | Multimorbidity | Decision Making | General PracticeUnited Kingdom
-
Gaziantep Islam Science and Technology UniversityNot yet recruiting
-
St. Jude Children's Research HospitalRecruitingKnowledge, Attitudes, PracticeUnited States
-
Pamela HughesRecruitingKnowledge, Attitudes, PracticeUnited States
Clinical Trials on The 15-Method
-
Nanfang Hospital of Southern Medical UniversityCompleted
-
Istanbul University - Cerrahpasa (IUC)CompletedMultisensory StimulationTurkey
-
Universidad Nacional de ColombiaCompleted
-
Hasan Kalyoncu UniversityNot yet recruitingAsthma | Patient EducationTurkey
-
Alberta Children's HospitalCompletedClubfoot | Ponseti Method | Talipes Equinovarus | CastingCanada
-
Meshalkin Research Institute of Pathology of CirculationRecruitingCoronary Artery Disease | Surgery | Graft Failure | Coronary Artery Stenosis | Cardiac IschemiaRussian Federation
-
Shanghai Chest HospitalRecruiting
-
Shanghai Chest HospitalUnknownLung NeoplasmsChina
-
Centre Hospitalier Universitaire de BesanconUniversity Hospital, Strasbourg, France; University Hospital, Clermont-Ferrand and other collaboratorsUnknown